Correlation Between Pliant Therapeutics and Black Diamond

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Black Diamond at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Black Diamond into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Black Diamond Therapeutics, you can compare the effects of market volatilities on Pliant Therapeutics and Black Diamond and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Black Diamond. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Black Diamond.

Diversification Opportunities for Pliant Therapeutics and Black Diamond

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pliant and Black is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Black Diamond Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Black Diamond Therap and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Black Diamond. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Black Diamond Therap has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Black Diamond go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Black Diamond

Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Black Diamond. In addition to that, Pliant Therapeutics is 2.39 times more volatile than Black Diamond Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Black Diamond Therapeutics is currently generating about -0.06 per unit of volatility. If you would invest  215.00  in Black Diamond Therapeutics on December 28, 2024 and sell it today you would lose (54.00) from holding Black Diamond Therapeutics or give up 25.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  Black Diamond Therapeutics

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pliant Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Black Diamond Therap 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Black Diamond Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pliant Therapeutics and Black Diamond Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Black Diamond

The main advantage of trading using opposite Pliant Therapeutics and Black Diamond positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Black Diamond can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Black Diamond will offset losses from the drop in Black Diamond's long position.
The idea behind Pliant Therapeutics and Black Diamond Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.